Top compounds associated with response to LRRC9


Feature Type Standardized
Nominal ANOVA
mRNA tacedinaline CTRPv2 pan-cancer AAC 0.16 8e-06
mRNA PD-0325901 gCSI pan-cancer AAC -0.22 2e-05
mRNA ABT-199 CTRPv2 pan-cancer AAC 0.18 2e-05
mRNA sotrastaurin CTRPv2 pan-cancer AAC 0.16 2e-05
mRNA necrosulfonamide CTRPv2 pan-cancer AAC 0.16 3e-05
mRNA CCT036477 CTRPv2 pan-cancer AAC 0.13 6e-05
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 7e-05
mRNA KPT185 CTRPv2 pan-cancer AAC 0.15 9e-05
mRNA piperlongumine:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 0.0001
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.13 0.0002
Download CSV